ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,69%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
83,95
0,47%
Bitcoin
62 979,28
2,93%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. bluebird bio Inc (BLUE)

  7. bluebird bio Inc (BLUE) Actualités

BLUE

bluebird bio (BLUE)

bluebird bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BLUE
DateHeureSourceTitreSymboleSociété
09/05/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLUEbluebird bio Inc
09/05/202413h00Business Wirebluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
07/05/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUENASDAQ:BLUEbluebird bio Inc
06/05/202413h05Business Wirebluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor EventsNASDAQ:BLUEbluebird bio Inc
06/05/202413h00Business Wirebluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene TherapyNASDAQ:BLUEbluebird bio Inc
03/05/202411h45PR Newswire (US)Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:BLUEbluebird bio Inc
26/04/202422h05Business Wirebluebird bio Announces Receipt of Expected Notice from NasdaqNASDAQ:BLUEbluebird bio Inc
26/04/202411h45PR Newswire (US)BLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:BLUEbluebird bio Inc
19/04/202411h45PR Newswire (US)bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUENASDAQ:BLUEbluebird bio Inc
16/04/202411h45PR Newswire (US)Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:BLUEbluebird bio Inc
12/04/202411h45PR Newswire (US)Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BLUEbluebird bio Inc
11/04/202414h00Business Wirebluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BLUEbluebird bio Inc
09/04/202411h45PR Newswire (US)bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUENASDAQ:BLUEbluebird bio Inc
05/04/202411h45PR Newswire (US)Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact The Gross Law Firm about pending Class Action - BLUENASDAQ:BLUEbluebird bio Inc
26/03/202412h01Business Wirebluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
25/03/202421h05Business Wirebluebird bio to Host Fourth Quarter and 2023 Annual Results Conference CallNASDAQ:BLUEbluebird bio Inc
18/03/202413h00Business Wirebluebird bio Secures up to $175 Million Debt Financing with Hercules CapitalNASDAQ:BLUEbluebird bio Inc
11/03/202413h00Business Wirebluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene TherapyNASDAQ:BLUEbluebird bio Inc
05/03/202423h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
14/02/202419h54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUEbluebird bio Inc
08/01/202422h35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUEbluebird bio Inc
08/01/202414h00Business Wirebluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial OutlookNASDAQ:BLUEbluebird bio Inc
02/01/202414h00Business Wirebluebird bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BLUEbluebird bio Inc
20/12/202323h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BLUEbluebird bio Inc
20/12/202303h41Business Wirebluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common StockNASDAQ:BLUEbluebird bio Inc
19/12/202312h10IH Market NewsGoogle $700M Antitrust Settlement, TSMC Chairman Retirement, Tesla Nevada Wage Hike, and MoreNASDAQ:BLUEbluebird bio Inc
18/12/202322h01Business Wirebluebird bio, Inc. Announces Proposed Public Offering of Common StockNASDAQ:BLUEbluebird bio Inc
10/12/202318h02Business WireLong-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb LevelsNASDAQ:BLUEbluebird bio Inc
09/12/202317h31Business WireLong-term Follow-up Data From bluebird’s Gene Therapy Program in Sickle Cell Disease Support Durable, Potentially Curative Benefits Through Stable Production of Anti-Sickling Adult Hemoglobin and Resolution of Vaso-Occlusive EventsNASDAQ:BLUEbluebird bio Inc
08/12/202322h11Dow Jones NewsBluebird Bio Shares Slide 41% on Black-Box Label, Higher Price for Sickle-Cell TreatmentNASDAQ:BLUEbluebird bio Inc
 Showing the most relevant articles for your search:NASDAQ:BLUE

Dernières Valeurs Consultées

EU
HO
Thales
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
EU
EN
Bouygues
COIN
BTCUSD
Bitcoin
EU
BEL20
Bel 20
EU
AI
Air Liquide
EU
GLE
Societe Generale
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
FTSE
UKX
FTSE 100
NYSE
KO
Coca Cola
EU
BNP
BNP Paribas
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés